Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection
Berkeley Heights, New Jersey, December 18, 2024 Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, announced today that the U.S. Food and Drug Administration has granted final approval of its Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) Multi-Dose Vial which it […]
